References
- Burch R. M., Kyle D. Receptor binding screening for receptor antagonists: methods for high volume throughput and data handling. Pharmaceutical Res. 1990, in press
- Dower S. K., Call S. M., Gillis S., Urdal D. L. Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc. Natl. Acad. Sic. USA 1986; 83: 1060–1064
- Sims J. E., March C. J., Cosman D., Widmer M. B., MacDonald H. R., McMahan C. J., Grubin C. E., Wignall J. M., Jackson J. L., Call S. M., Friend D., Alpert A. R., Gillis S., Urdal D. L., Dower S. K. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobin superfamily. Science 1988; 241: 585–589
- Sims J. E., Acres R. B., Grubin C. E., McMahan C. J., Wignall J. M., March C. J., Dower S. K. Cloning the interleukin 1 receptor from human T cells. Proc. Natl. Acad. Sci. USA 1989; 86: 8946–8950
- Farmer S. G., Burch R. M., DeHaas C. J., Togo J., Steranka L. R. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin-and vasopressin-induced contractions of uterine smooth muscle. J. Pharmacol. Exp. Ther. 1989; 248: 677–681
- Burch R. M., Connor J. R., Axelrod J. Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 1988; 85: 6306–6309
- Braas K. M., Manning D. C., Perry D. C., Snyder S. H. Bradykinin analogues: differential agonist and antagonist activities suggest multiple receptors. Brit. J. Pharmacol. 1988; 94: 3–5
- de Vries J. G., Phillips E., Snell C. R., Snell P. H., Webb M. Construction of a physiologically active photoaffinity probe based on the structure of bradykinin: labelling of angiotensin converting enzyme but not candidate bradykinin receptors on NG108–15 cells. J. Neurochem. 1989; 52: 1508–1516
- Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 1989; 35: 469–476
- DeLean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Bio. Chem. 1980; 255: 7108–7117
- Stewart J., Vavrek R. B2 bradykinin antagonists. Bradykinin Antagonists: Basic and Clinical Research, R. M. Burch. Marcel Dekker. 1990, in press
- Farmer S. G., Burch R. M., DeHaas C. J., Togo J., Steranka L. R. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin-and vasopressin-induced contractions of uterine smooth muscle. J. Pharmacol. Exp. Ther. 1989; 248: 677–681